Expert review of anticancer therapy
-
Expert Rev Anticancer Ther · Jan 2012
ReviewTreatment of elderly patients with stage IV non-small-cell lung cancer.
Every thoracic oncologist could be considered a geriatric oncologist as the median age of presentation with metastatic non-small-cell lung cancer is 71 years. Subgroup analyses and population-based studies suggest similar benefits to treatment of the fit elderly compared with younger patients. ⋯ Comprehensive geriatric assessment can augment the standard examination in defining the strengths and weakness of the elderly patient who is considering chemotherapy. In the future, biochemical assessment of physiologic age may further aid this assessment.